Reuters Health Report

Click to View in Browser 12/16/2013 Analysis: Fight for cheap drugs shifts from AIDS to new hepatitis pills LONDON (Reuters) - A new battle is looming over access to antiviral medicines in developing countries - this time for treating hepatitis C - more than a decade after a global showdown over the price of AIDS drugs in Africa. JPMorgan, other employers move to cover costly autism therapies Boston (REUTERS) - Michael Giangregorio's son Nicholas was diagnosed as severely autistic when he was 18 months old. Now 12, Nicholas requires nearly round-the-clock care - special schooling as well as speech, occupational and physical therapy - that can cost tens of thousands of dollars a year. Siemens, Pfizer to cooperate on diagnostic tests FRANKFURT (Reuters) - Germany's Siemens agreed to cooperate with Pfizer on diagnostic tests for therapeutic products across the U.S. drugmaker's pipeline. U.S. Supreme Court refuses to hear ex-InterMune CEO's appeal WASHINGTON (Reuters) - The U.S. Supreme Court on Monday said it would not review the fraud conviction of former InterMune Inc Chief Executive Scott Harkonen for a statement he made about the effectiveness of one of the company's drugs. Endo Health to acquire Nupathe for $105 million (Reuters) - Specialty pharmaceutical company Endo Health Solutions Inc said it would buy NuPathe Inc for about $105 million to gain access to NuPathe's migraine treatment, Zecuity. Agenus brain cancer vaccine shows promise in study (Reuters) - Agenus Inc said more than 90 percent of patients treated with its experimental brain cancer vaccine were alive six months after undergoing surgery to remove the tumors. FDA proposes tighter rules on antibacterial soaps (Reuters) - U.S. regulators on Monday issued a proposed rule that would require makers of antibacterial hand soaps and body washes to demonstrate their products are safe and more effective than soap and water in preventing infection and the spread of bacteria. Cubist antibiotic succeeds in late-stage trial, shares rise (Reuters) - Cubist Pharmaceuticals Inc said its experimental antibiotic for treating abdominal infections was found as effective as a widely used antibiotic in a late-stage trial. Lundbeck hopes to launch new Alzheimer's drug in 2017 COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck said on Monday that it hopes to launch a new Alzheimer's medicine in 2017 in what would be the first new drug for the condition in more than a decade. Avoid raw milk due to infection risks: pediatricians NEW YORK (Reuters Health) - Pregnant women, babies and kids should not drink raw or unpasteurized milk, a group of pediatricians said on Monday. Related Video Sea Shepherd ships prepare for departure Snow blasts U.S. Northeast The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend